Laird Superfood Grows Revenue But Faces Inflation Uncertainties
Summary
- Laird Superfood IPO'd in September 2020 and raised $58 million in gross proceeds.
- The firm manufactures plant-based and functional foods for consumers in the United States.
- LSF has grown revenue but faces inflationary and supply chain uncertainties as well as continuing to generate high operating losses.
- My short-term outlook on the stock is Neutral.
- Looking for more investing ideas like this one? Get them exclusively at IPO Edge. Learn More »
Rocky89/E+ via Getty Images
Quick Take On Laird Superfood
Laird Superfood (NYSE:LSF) went public in September 2020, raising $58 million in gross proceeds in an IPO that was priced at $22.00 per share.
The firm designs and manufactures plant-based and functional food products in the United States.
The combination of inflation risks and the firm’s poor operating results since IPO leave me Neutral on its stock price at around $13.40.
Until management can produce a meaningful and sustained move toward operating breakeven while maintaining topline revenue growth, I don’t see a major upside catalyst to LSF.
Company
Sisters, Oregon-based Laird was founded to source and develop plant-based and functional food and beverage products for consumers in the U.S Natural, Organic and Functional Food and Beverages category.
Management is headed by Co-founder and CEO Paul Hodge Jr. and Co-founder Laird Hamilton.
Mr. Hodge previously founded GolfBoard and Mr. Hamilton is known for his 'accomplishments in big wave surfing.'
Below is a brief overview video of Laird's mission:
(Source)
The firm is creating what it calls 'an emerging platform within the rapidly expanding plant-based natural foods industry.’
The firm distributes its products through three channels:
Online
Wholesale
Food Service
Laird sells online through its dedicated website and through Amazon, which 'in 2019 and the first six months of 2020, the online business made up 58.4% and 57.1% of [its] net sales, respectively.' (Source)
Market & Competition
According to a 2019 market research report by Food Business News, the U.S. market for organic food, of which Laird is in a subset of, reached an estimated $47.9 billion in 2018, growing by 5.9% in that year.
Overall, organic food sales accounted for 5.7% of total U.S. food sales.
Notably, non-food sales grew at nearly an 11% annual rate in 2018.
Also, organic fruits and vegetables made up more than a third, 36%, of all organic food sales in 2018.
Milk alternatives as well as plant-based foods have proven to be popular among millennials as they have begun moving away from livestock-based products for environmental reasons.
Major competitive or other industry participants include:
Nestle (OTCPK:NSRGY)
Danone (OTCQX:DANOY)
TreeHouse Foods (THS)
Califia Farms
Coca-Cola (KO)
PepsiCo (PEP)
Body Armor
Vita Coco (COCO)
Management says it believes its competition is primarily 'legacy products that are refined-sugar laden, highly processed, and have undecipherable ingredient lists. We believe consumers want more transparency and understanding of what they are putting in their bodies and are seeking less-processed alternatives.'
(Source)
Laird’s Recent Financial Performance
Topline revenue by quarter has risen in recent quarters:
Gross profit by quarter has produced growth in the past three quarters:
Operating loss by quarter has generally increased except in Q3 2021:
Loss per share (Diluted) has remained significant since the firm’s IPO:
(Source data for above GAAP financial charts)
In the past 12 months, LSF’s stock price has dropped 72.4 percent vs. the U.S. S&P 500 index’ rise of 27.5 percent, as the chart below indicates:
(Source)
Valuation Metrics For LSF
Below is a table of relevant capitalization and valuation figures for the company:
Measure | Amount |
Market Capitalization | $118,070,000 |
Enterprise Value | $86,960,000 |
Price / Sales | 3.34 |
Enterprise Value / Sales | 2.49 |
Enterprise Value / EBITDA | -3.47 |
Free Cash Flow [TTM] | -$26,060,000 |
Revenue Growth Rate [TTM] | 54.18% |
Earnings Per Share | -$2.40 |
(Source)
As a reference, a relevant public comparable to LSF would be The Vita Coco Company (COCO); shown below is a comparison of their primary valuation metrics:
Metric | Vita Coco (COCO) | Laird Superfood (LSF) | Variance |
Price / Sales | 1.68 | 3.34 | 98.8% |
Enterprise Value / Sales | 1.72 | 2.49 | 44.8% |
Enterprise Value / EBITDA | 17.52 | -3.47 | -119.8% |
Revenue Growth Rate | 9.4% | 54.2% | 476.4% |
(Source)
Commentary On Laird
In its last earnings call, covering Q3 2021’s results, management highlighted its key metric performance for its direct-to-consumer business [DTC], such as a ‘30% improvement in AOV (Average Order Value)’ and higher first and second retention rates.
Notably, recurring revenue for repeat and subscription orders now accounts for more than 67% of its DTC revenue.
Wholesale grocery sales improved while its refrigerated products saw a reduction in DC spoils.
Category growth appeared to be solid across most products with the exception of its Coffee, Tea & Hot Chocolate product category down due to ‘a large initial trial on club’ for the previous year’s same period.
The company is in the latter stages of searching for a new CEO with CPG experience while sharing the firm’s values.
As to its financial results, while topline revenue produced accelerating growth, GAAP operating losses and net loss remained significant, with little meaningful move toward operating breakeven over the last several quarters.
G&A expenses as a percentage of net sales rose, while sales and marketing expenses dropped due to lower stock-based compensation and personnel costs.
Regarding valuation, LSF is currently being valued by investors at significantly higher multiples than The Vita Coco Company, although LSF is growing topline revenue at a far higher rate, so the current valuation appears comparatively justified.
The primary risk to the company’s outlook is the rise in inflationary pressures, both on direct product costs as well as in transportation costs and potential delays.
Management says its transportation chains largely bypass the most impacted ports and that it is pursuing strategic pricing efforts to reduce the impact of inflation, at least in the short term.
The combination of inflation risks and the firm’s poor operating results since IPO leave me Neutral on its stock price at around $13.40.
Until management can produce a meaningful and sustained move toward operating breakeven while maintaining topline revenue growth, I don’t see a major upside catalyst to LSF.
Gain Insight and actionable information on U.S. IPOs with IPO Edge research.
Members of IPO Edge get the latest IPO research, news, and industry analysis.
Get started with a free trial!
This article was written by
Donovan Jones is an IPO research specialist with 15 years of experience identifying opportunities for IPOs. He focuses on high-growth technology, consumer, and life science companies.
He leads the investing group IPO Edge which offers: actionable information on growth stocks through first look S-1 filings, previews on upcoming IPOs, an IPO calendar for tracking what’s on the horizon, a database of U.S. IPOs, and a guide to IPO investing to walk you through the entire IPO lifecycle - from filing to listing to quiet period and lockup expiration dates. Learn more.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
This report is intended for educational purposes only and is not financial, legal or investment advice. The information referenced or contained herein may change, be in error, become outdated and irrelevant, or removed at any time without notice. You should perform your own research for your particular financial situation before making any decisions.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Recommended For You
Comments (8)



